Skip to main content
Citadel Group logo

Citadel Group — Investor Relations & Filings

Ticker · CGL ISIN · AU000000CGL3 LEI · 213800FIHTDHRZIC4882 ASX Financial and insurance activities
Open in API
Filings indexed 2,077 across all filing types
Latest filing 2025-08-11 Major Shareholding Noti…
Country AU Australia
Listing ASX CGL

About Citadel Group

https://www.citadelgroup.com.au/

Citadel Group is a software and technology company specializing in secure enterprise information management for complex environments. The firm develops and delivers software applications, digital platforms, managed services, and IT solutions. It primarily serves government departments and large corporate clients, with a focus on managing system-critical data. The company also provides solutions for the healthcare sector aimed at improving patient outcomes. The organization has evolved and now operates under the name Citadel Edge.

Recent filings

Filing Released Lang Actions
Form 8.3 - American Axle & Manufacturing Holdings
Major Shareholding Notification Classification · 95% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in an offeror or offeree company (in this case, American Axle Manufacturing Holdings Inc). This type of document is a specific regulatory disclosure required during M&A activity, and it fits best under the 'Major Shareholding Notification' category as it tracks significant ownership and dealings related to takeover thresholds.
2025-08-11 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 97% confidence The document is a 'Form 8.3' filing, which is a standard regulatory disclosure required under the Irish Takeover Panel Act, 1997, and the Takeover Rules, 2022. It details the opening position and dealings in relevant securities of an offeror/offeree (Mural Oncology PLC) by a major shareholder (Citadel Group). This type of filing is specifically used to notify the market of significant shareholding changes and derivative positions during a takeover or merger process. While it relates to M&A activity, it is a specific regulatory disclosure form rather than a general M&A announcement, and it fits the definition of a Major Shareholding Notification (MRQ) or a Regulatory Filing (RNS). Given the specific nature of the Irish Takeover Panel disclosure, it is best classified as a Major Shareholding Notification.
2025-08-11 English
Form 8.3 - Dowlais Group Plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details the public opening position and dealing disclosures by a person with interests in relevant securities representing 1% or more of an offeror or offeree. This type of document is a specific regulatory requirement for transparency during M&A activity and does not fit into the other categories like M&A announcements (TAR) or major shareholding notifications (MRQ) as it is a specific transactional disclosure form. Therefore, it is classified as a Regulatory Filing (RNS).
2025-08-11 English
Form 8.3 - American Axle & Manufacturing Holdings
Major Shareholding Notification Classification · 100% confidence The document is a 'FORM 8.3' disclosure, which is a standard regulatory filing under the UK Takeover Code. It details 'Public Opening Position Disclosure/Dealing Disclosure' by a person with interests in relevant securities representing 1% or more. This document type is specifically used for reporting shareholdings and dealings in the context of a takeover or merger, which falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership and changes in holdings related to an offeror/offeree.
2025-08-08 English
Form 8.3 - Mural Oncology plc
Major Shareholding Notification Classification · 98% confidence The document is a 'Form 8.3' disclosure, which is a standard regulatory filing required under the Irish Takeover Panel Act. It details the opening position and dealings in the securities of Mural Oncology PLC by Citadel Group. This type of disclosure is a mandatory regulatory filing related to M&A activity (takeover rules), but since it is a specific regulatory form for disclosure of interests, it falls under the 'Regulatory Filings' category as the most appropriate classification for this type of mandatory disclosure.
2025-08-08 English
Form 8.3 - Dowlais Group Plc
Regulatory Filings Classification · 100% confidence The document is a 'Form 8.3' disclosure, which is a mandatory regulatory filing under the UK Takeover Code. It details the opening position and dealings in relevant securities by a person with interests representing 1% or more in a company involved in a takeover (Dowlais Group PLC). This type of disclosure is a specific regulatory requirement for market surveillance and does not fit into categories like M&A activity (which usually refers to the company's own announcements) or major shareholding notifications (which are typically TR-1 forms). Therefore, it is classified as a Regulatory Filing (RNS).
2025-08-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.